35356-335 : Ms Contin 15 mg Extended Release Tablet

NDC:	35356-335
Labeler:	Lake Erie Medical Dba Quality Care Products LLC
Product Type:	Human Prescription Drug
Drug Name:	Ms Contin
Dosage Form:	Oral Tablet, Film Coated, Extended Release
Application #:	NDA019516
Rev. Date:	Jan 31, 2011
CSA Schedule:	CII (US) [1]

^[1] Schedule II / IIN Controlled Substance: High potential for abuse which may lead to severe psychological or physical dependence. (i.e. Narcotics such as Dilaudid, Methadone, Demerol, Oxycodone, Percocet, Fentanyl, Morphine, Opium, Codeine, and Hydrocodone ... Schedule IIN stimulants include non-narcotic Amphetamines such as Dexedrine, Adderall, Desoxyn, Methylphenidate (Ritalin) ... Other Schedule II substances include Amobarbital, Glutethimide, and Pentobarbital. More Details: US Dept of Justice Controlled Substance Schedules.

Appearance:

Markings:	M;15
Shapes:	Round
Colors:	Blue
Size (mm):	7
Segments: *	1
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

• 35356-335-60: 60 TABLET, FILM COATED, EXTENDED RELEASE IN 1 BOTTLE, PLASTIC (35356‑335‑60)

Active Ingredients:

• Morphine Sulfate

Inactive Ingredients:

• Cetostearyl Alcohol
• Hydroxyethyl Cellulose (140 Cps At 5%)
• Hypromelloses
• Magnesium Stearate
• Polyethylene Glycol
• Talc
• Titanium Dioxide
• Fd&c Blue No. 2
• Lactose
• Polysorbate 80

Pharmaceutical Classes:

• Full Opioid Agonists [MoA]
• Opioid Agonist [EPC]

Related Products:

Based on records with the same trade name.

• 16590-884 Ms Contin 60 mg Extended Release Tablet by Stat Rx USA LLC
• 42858-515 Ms Contin 15 mg Oral Tablet by Rhodes Pharmaceuticals L.p.
• 42858-631 Ms Contin 30 mg Oral Tablet by Rhodes Pharmaceuticals L.p.
• 42858-760 Ms Contin 60 mg Oral Tablet by Rhodes Pharmaceuticals L.p.
• 42858-799 Ms Contin 100 mg Oral Tablet by Rhodes Pharmaceuticals L.p.
• 42858-900 Ms Contin 200 mg Oral Tablet by Rhodes Pharmaceuticals L.p.
• 55154-4706 Ms Contin 30 mg Extended Release Tablet by Cardinal Health
• 55154-4707 Ms Contin 60 mg Extended Release Tablet by Cardinal Health
• 55154-4708 Ms Contin 100 mg Extended Release Tablet by Cardinal Health
• 59011-260 Ms Contin 15 mg Extended Release Tablet by Purdue Pharma Lp
• 59011-261 Ms Contin 30 mg Extended Release Tablet by Purdue Pharma Lp
• 59011-262 Ms Contin 60 mg Extended Release Tablet by Purdue Pharma Lp
• 59011-263 Ms Contin 100 mg Extended Release Tablet by Purdue Pharma Lp
• 59011-264 Ms Contin 200 mg Extended Release Tablet by Purdue Pharma Lp

NDC QR Code

Scan the QR code below to easily reference this data in the future:



< Prev: 35356-333Next: 35356-339 >

Related Discussions: